<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4835480</article-id><article-id pub-id-type="doi">10.3389/fcimb.2016.00044</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>GidA, a tRNA Modification Enzyme, Contributes to the Growth, and Virulence of Streptococcus suis Serotype 2 </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/340391/overview"/></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Meifang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/340384/overview"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Wanquan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chunyan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/340387/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Tengfei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/340392/overview"/></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Linlin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Jiawen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/340423/overview"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/200819/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University</institution><country>Wuhan, China</country></aff><aff id="aff2"><sup>2</sup><institution>Veterinary Medicine Laboratory, Institute of Animal Husbandry and Veterinary Science, Hubei Academy of Agricultural Science</institution><country>Wuhan, China</country></aff><aff id="aff3"><sup>3</sup><institution>Wuhan Chopper Biology Co., Ltd.</institution><country>Wuhan, China</country></aff><aff id="aff4"><sup>4</sup><institution>Cooperative Innovation Center of Sustainable Pig Production</institution><country>Wuhan, China</country></aff><author-notes><fn fn-type="edited-by"><p><text><SENT sid="1" pm="."><plain>Edited by: Matthew S. </plain></SENT>
<SENT sid="2" pm="."><plain>Francis, Umeå University, Sweden </plain></SENT>
</text></p></fn><fn fn-type="edited-by"><p><text><SENT sid="3" pm="."><plain>Reviewed by: Michael Marceau, University of Lille, France; Jesus Aranda, Universitat Autònoma de Barcelona, Spain; Amin A. </plain></SENT>
<SENT sid="4" pm="."><plain>Fadl, University of Wisconsin-Madison, USA </plain></SENT>
</text></p></fn><corresp id="fn001">*Correspondence: Rui Zhou <email xlink:type="simple">rzhou@mail.hzau.edu.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>6</volume><elocation-id>44</elocation-id><history><date date-type="received"><day>02</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement>Copyright © 2016 Gao, Tan, Liu, Zhang, Zhang, Zheng, Zhu, Li and Zhou.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Gao, Tan, Liu, Zhang, Zhang, Zheng, Zhu, Li and Zhou</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="5" pm="."><plain>Glucose-inhibited division protein (GidA), is a tRNA modification enzyme functioning together with MnmE in the addition of a carboxymethylaminomethyl group to position 5 of the anticodon wobble uridine of tRNA. </plain></SENT>
<SENT sid="6" pm="."><plain>Here, we report a GidA homolog from a Chinese isolate SC-19 of the zoonotic Streptococcus suis serotype 2 (SS2). gidA disruption led to a defective growth, increased capsule thickness, and reduced hemolytic activity. </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, the gidA deletion mutant (ΔgidA) displayed reduced mortality and bacterial loads in mice, reduced ability of adhesion to and invasion in epithelial cells, and increased sensitivity to phagocytosis. </plain></SENT>
<SENT sid="8" pm="."><plain>The iTRAQ analysis identified 372 differentially expressed (182 up- and 190 down-regulated) proteins in ΔgidA and SC-19. </plain></SENT>
<SENT sid="9" pm="."><plain>Numerous DNA replication, cell division, and virulence associated proteins were downregulated, whereas many capsule synthesis enzymes were upregulated by gidA disruption. </plain></SENT>
<SENT sid="10" pm="."><plain>This is consistent with the phenotypes of the mutant. </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, GidA is a translational regulator that plays an important role in the growth, cell division, capsule biosynthesis, and virulence of SS2. </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings provide new insight into the regulatory function of GidA in bacterial pathogens. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd><italic>Streptococcus suis</italic> (<italic>S. suis</italic>)</kwd><kwd>glucose-inhibited division protein (GidA)</kwd><kwd>tRNA modification</kwd><kwd>iTRAQ</kwd><kwd>growth</kwd><kwd>capsule synthesis</kwd><kwd>virulence</kwd></kwd-group></SecTag><counts><fig-count count="5"/><table-count count="3"/><equation-count count="0"/><ref-count count="53"/><page-count count="11"/><word-count count="7789"/></counts></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="s1"><title><text><SENT sid="13" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="14" pm="."><plain>Streptococcus suis is an important zoonotic pathogen causing lethal infections in humans and pigs (Lun et al., 2007). S. suis infection in human is an emerging public health issue, whereas that in pigs causes severe economic problems in the pig industry (Wertheim et al., 2009). </plain></SENT>
<SENT sid="15" pm="."><plain>Two large outbreak of human S. suis infections were reported in China in 1998 and 2005, resulting in 229 infections and 52 deaths (Yu et al., 2006; Lun et al., 2007). </plain></SENT>
<SENT sid="16" pm="."><plain>Among the 33 serotypes classified on the basis of antigenicity of capsular polysaccharide (CPS), S. suis serotype 2 (SS2) is the most virulent and prevalent strain isolated from diseased pigs (Smith et al., 1999). </plain></SENT>
<SENT sid="17" pm="."><plain>Several virulence-associated factors responsible for the pathogenecity of S. suis, such as muramidase-released protein, suilysin (Sly), extracellular factor, fibrinonectin- and fibrinogen-binding proteins, enolase, arginine deiminase system (ADS), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), were identified over the past decade (Jing et al., 2008; Feng et al., 2014). </plain></SENT>
</text></p><p><text><SENT sid="18" pm="."><plain>S. suis infection is a major cause of meningitis, septicemia, and arthritis. S. suis primarily colonizes the palatine tonsils, which is one of its natural habitats, then breaches epithelial cell barriers, reaches the bloodstream, disseminates through the blood circulation system, and finally invades different organs of the host (Fittipaldi et al., 2012). </plain></SENT>
<SENT sid="19" pm="."><plain>In this process, many proteins are regulated (up-regulated or down-regulated) at the translation level in response to surroundings change and environmental signals. </plain></SENT>
<SENT sid="20" pm="."><plain>However, the regulatory mechanism of genes which are preferentially regulated by this pathogen during specific stages of host infection has not yet been clearly demonstrated. </plain></SENT>
<SENT sid="21" pm="."><plain>GidA-like proteins, functioning as a tRNA modification enzyme, are widely distributed in nature and conserved among eukaryotes and prokaryotes (Yim et al., 2006). </plain></SENT>
<SENT sid="22" pm="."><plain>GidA is a FAD-binding protein and, together with MnmE, catalyzes the addition of carboxymethylaminomethyl group at position 5 of the wobble uridine of tRNAs (Shi et al., 2009). </plain></SENT>
<SENT sid="23" pm="."><plain>This modification contributes to proper and efficient protein translation (Fislage et al., 2014). </plain></SENT>
<SENT sid="24" pm="."><plain>GidA and MnmE serve essentially to prevent premature translation termination resulting from (+2) translational frameshifts (Brégeon et al., 2001). </plain></SENT>
<SENT sid="25" pm="."><plain>GidA protein plays a different role in many bacteria: in Escherichia coli, deletion of gidA affects cell division when it is grown on glucose (Von Meyenburg et al., 1982); in Streptococcus mutans, gidA is involved in survival under stress conditions (Li et al., 2014); in Aeromonas hydrophila, gidA regulates virulence protein, cytotoxic enterotoxin (Sha et al., 2004); in Salmonella enterica, disruption of gidA affects cell division and regulates the virulence proteins (Shippy et al., 2012; Rehl et al., 2013); and in Pseudomonas syringae, gidA is a global regulator (Kinscherf and Willis, 2002). </plain></SENT>
<SENT sid="26" pm="."><plain>In fact, GidA can regulate the expression of multiple proteins at the level of translation through tRNA modification (Kinscherf and Willis, 2002; Yim et al., 2006), and thus can regulate the survival of bacteria under stress condition in response to environmental signals. </plain></SENT>
</text></p><p><text><SENT sid="27" pm="."><plain>In our previous study, the gidA gene was identified to be up-regulated in the brains and lungs of S. suis infected pigs, suggesting that GidA may play a role during the infection (Li et al., 2010). </plain></SENT>
<SENT sid="28" pm="."><plain>In this study, we identified a functional gene SSU05_2163, which is annotated as gidA in S. suis 05ZYH33 genome and encodes a tRNA modification enzyme. </plain></SENT>
<SENT sid="29" pm="."><plain>Our data demonstrate that GidA is a translational regulator that affects cell growth and division, capsule polysaccharide biosynthesis, and expression of virulence proteins in S.suis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials and methods" id="s2"><title><text><SENT sid="30" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec><title><text><SENT sid="31" pm="."><plain>Bacterial strains, plasmids, and growth conditions </plain></SENT>
</text></title><p><text><SENT sid="32" pm="."><plain>The bacterial strains and plasmids used in this study are listed in Table 1. </plain></SENT>
<SENT sid="33" pm="."><plain>The SS2 strain SC-19 was isolated from a sick pig during an epidemic outbreak in Sichuan Province in China in 2005 (Li et al., 2009). </plain></SENT>
<SENT sid="34" pm="."><plain>Bacterial solution for experiment was prepared as follows: SC-19 and ΔgidA were grown at 37°C either in tryptic soy broth, or on tryptone soy agar (Difco, France) containing 10% fetal bovine serum (Sijiqing, Hanzhou, China), and then the cultures were centrifuged and washed thrice with saline. </plain></SENT>
<SENT sid="35" pm="."><plain>To be consistent with the isobaric tags for relative and absolute quantitation (iTRAQ) analysis, all of the bacterial pellets were resuspended in the chemically defined medium (CDM) (Van De Rijn and Kessler, 1980) supplemented with 1% glucose and grown to mid-log phase at 37°C. E. coli DH5α was used as host strain for cloning and maintained in Luria-Bertani (LB) broth (Difco) or plated on LB agar at 37°C. </plain></SENT>
<SENT sid="36" pm="."><plain>The antibiotic concentration prepared for wild-type SC-19 was 20 μg/ml streptomycin. </plain></SENT>
<SENT sid="37" pm="."><plain>The antibiotic concentrations used to select the mutant strain ΔgidA were 100 μg/ml for spectinomycin and 90 μg/ml for erythromycin. </plain></SENT>
<SENT sid="38" pm="."><plain>The kanamycin concentration used to select E. coli strains harboring the plasmid of interest was 25 μg/ml. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><text><SENT sid="39" pm="."><plain>Summary of bacterial strains and plasmid used in this study. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="40" pm="."><plain>Strain or plasmid </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="41" pm="."><plain>Characteristics and functiona </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="42" pm="."><plain>Sources or references </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" style="background-color:#bdbec1" rowspan="1"><text><SENT sid="43" pm="."><plain>BACTERIAL STRAINS </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="44" pm="."><plain>SC-19 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="45" pm="."><plain>S. suis serotype 2, wide- type (Strep r) </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="46" pm="."><plain>Li et al., 2009 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="47" pm="."><plain>ΔgidA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="48" pm="."><plain>SC-19 gidA::erm (Strep r Erm r) </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="49" pm="."><plain>This study </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>E. coli DH5α </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>Cloning host for recombinant vector </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="52" pm="."><plain>Trans </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="3" style="background-color:#bdbec1" rowspan="1"><text><SENT sid="53" pm="."><plain>PLASMID </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>pAT18 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>Contains an Erm r gene expressing erythromycin resistance rRNA methylase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="56" pm="."><plain>Trieu-Cuot et al., 1991 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>pET28a </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>Expression vector; Kan r </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>Novagen </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>pSET4s </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>E. coli- S. suis shuttle vector; Spc r </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>Takamatsu et al., 2001 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>pSET4s-G </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>Derived from pSET4s used to knock out gidA in SC-19; Spc r Erm r </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>This study </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="TN1"><label>a</label><p><text><SENT sid="66" pm="."><plain>Strep r, streptomycin resistant; Erm r, erythromycin resistant; Kan r, kanamycin; Spc r, spectinomycin, resistant. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec><title><text><SENT sid="67" pm="."><plain>Knockout of gidA </plain></SENT>
</text></title><p><text><SENT sid="68" pm="."><plain>To construct a ΔgidA mutant strain, we used the thermosensitive suicide vector pSET4s to delete gidA through homologous recombination as previously described (Takamatsu et al., 2001). </plain></SENT>
<SENT sid="69" pm="."><plain>Primers used in this study were designed according to the genome sequence of S. suis 05ZYH33 (GenBank accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="CP000407">CP000407</ext-link>; Table 2). </plain></SENT>
<SENT sid="70" pm="."><plain>Two pairs of specific primers, Gup-F/Gup-R and Gdown-F/Gdown-R were used to clone the gidA upstream and downstream of the homologous regions into pSET4s. </plain></SENT>
<SENT sid="71" pm="."><plain>The ermr expression cassette was amplified from pAT18 by using primers Erm-F/Erm-R and then inserted between the upstream and downstream homologous arms in the recombinant pSET4s to generate the gidA-knockout vector pSET4s-G. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><text><SENT sid="72" pm="."><plain>Primers used for PCR amplification and detection. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>Primers </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>Primers sequence (5′−3′)a </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>Amplification for </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>Gup-F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>CTTCAAGCTTGCTTTTGTGGACTTA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>Upstream border of gidA </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>Gup-R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>GTTTGTCGACTCATGTTGTTCTCTCCT </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>Gdown-F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>GATCCCGGGGGCTGTTCTTTTCGC </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>Downstream border of gidA </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>Gdown-R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>CCCCGAATTCTTCCTTGACCACAACC </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>Erm-F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>GTCTGGATCCCTTAGAAGCAAACTTAA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>Erm r gene </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>Erm-R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>GTTAGGATCCATCGATACAAATTCCCCG </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>GidA-F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>CGGGATCCATGACACACACATTTGCAGA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>gidA gene </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>GidA-R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>CGCTCGAGTTAGTGACTGTCCTTTGATTT </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>2162-F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>GTGATGAAAAGATTTCGATT </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>Downstream gene of gidA </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>2162-R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>TTATCCAAAGTCAAGCCA </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>2164-F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>GGTTGATTATAAAAGATGG </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>Upstream gene of gidA </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>2164-R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>TCATGTTGTTCTCTCCTT </plain></SENT>
</text></td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TN2"><label>a</label><p><text><SENT sid="106" pm="."><plain>Underlined nucleotides denote enzyme restriction sites. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="107" pm="."><plain>To obtain isogenic mutant ΔgidA, we electro transformed pSET4s-G plasmid into SC-19 competent cells (Zhang et al., 2012). </plain></SENT>
<SENT sid="108" pm="."><plain>The mutant strain was screened on TSA plates owing to its sensitivity to spectinomycin and resistance to erythromycin. </plain></SENT>
<SENT sid="109" pm="."><plain>To confirm the mutant, we amplified gidA through PCR by using the primers GidA-F/GidA-R. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="110" pm="."><plain>RNA extraction and RT-PCR </plain></SENT>
</text></title><p><text><SENT sid="111" pm="."><plain>To confirm the mutant strain ΔgidA, we performed RT-PCR according to our previously reported methods (Tan et al., 2015). </plain></SENT>
<SENT sid="112" pm="."><plain>Briefly, RNA was isolated using SV Total RNA Isolation System (Promega, USA) according to the manufacturer's instructions. </plain></SENT>
<SENT sid="113" pm="."><plain>In addition, cDNA was synthesized using HiScript Q Select RT SuperMix (Vazyme, China) according to the manufacturer's instructions. </plain></SENT>
</text></p><p><text><SENT sid="114" pm="."><plain>To confirm whether the upstream and downstream genes of gidA are unaffected and functioning normally, we designed the primers of SSU05_2162, gidA, and SSU05_2164 for RT-PCR (Table 2) from the cDNA. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="115" pm="."><plain>Western blot </plain></SENT>
</text></title><p><text><SENT sid="116" pm="."><plain>To further confirm the mutant strain ΔgidA, we performed Western blot analysis according to our previously reported methods (Tan et al., 2015). </plain></SENT>
<SENT sid="117" pm="."><plain>Mouse anti-GidA serum was produced as described previously (Li et al., 2011) by using recombinant GidA protein. </plain></SENT>
<SENT sid="118" pm="."><plain>The PVDF membranes (Invitrogen, USA) were probed with primary antibodies against GidA (1:1000) or 3-phosphoglycerate kinase (PGK) (1:5000; Invitrogen) (Zhang et al., 2014). </plain></SENT>
<SENT sid="119" pm="."><plain>After washing, the membranes were incubated with goat anti-mouse IgG (H+L)-HPR (1:5000; Southern Biotech, USA). </plain></SENT>
<SENT sid="120" pm="."><plain>Antibody-tagged protein bands were detected by using Western ECL Substrate Kit (Bio-Rad, USA). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="121" pm="."><plain>Transmission electron microscopy (TEM) </plain></SENT>
</text></title><p><text><SENT sid="122" pm="."><plain>To obtain an overview of the morphology of SC-19 and ΔgidA, we performed TEM as described previously (Zheng et al., 2011). </plain></SENT>
<SENT sid="123" pm="."><plain>The samples grown in CDM were harvested at mid-log phase and fixed with 2.5% glutaraldehyde overnight. </plain></SENT>
<SENT sid="124" pm="."><plain>The samples were then treated with 2% osmium tetroxide for 2 h and dehydrated in a serial dilution of ethanol. </plain></SENT>
<SENT sid="125" pm="."><plain>The dehydrated cells were embedded in epoxy resin and cell morphology was observed using an H-7650 TEM (HITACHI, Ltd., Tokyo, Japan). </plain></SENT>
<SENT sid="126" pm="."><plain>20 bacterial cells were randomly chosen from the TEM micrographs to measure the thickness of capsule by using the software Image J, and then statistically analyzed on GraphPad prism 5. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="127" pm="."><plain>Hemolysin assay </plain></SENT>
</text></title><p><text><SENT sid="128" pm="."><plain>Hemolysin activity was tested as described previously (Jacobs et al., 1994) with some modifications. </plain></SENT>
<SENT sid="129" pm="."><plain>Briefly, S. suis strains were grown in CDM up to mid-log phase, and the culture supernatant was collected by centrifugation at 12000 g for 2 min. </plain></SENT>
<SENT sid="130" pm="."><plain>The test samples (100 μl) were incubated with 2% sheep erythrocyte suspension (100 μl) in saline for 2 h at 37°C and CDM was used as negative control. </plain></SENT>
<SENT sid="131" pm="."><plain>Unlysed erythrocytes were centrifuged at 1500 g for 15 min, and 100 μl supernatant was transferred into a new plate (Jet Biofil, China). </plain></SENT>
<SENT sid="132" pm="."><plain>Absorption was subsequently measured at 550 nm by using a microELISA reader (Biotek, Vermont, USA). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="133" pm="."><plain>Mouse infection experiments </plain></SENT>
</text></title><p><text><SENT sid="134" pm="."><plain>This study was performed in accordance with the Guide for the Care and Use of Laboratory Animals Monitoring Committee of Hubei Province, China, and the protocol was approved by the Committee on the Ethics of Animal Experiments of the College of Veterinary Medicine, Huazhong Agricultural University. </plain></SENT>
<SENT sid="135" pm="."><plain>All efforts were made to minimize the suffering of the animals used in the study. </plain></SENT>
</text></p><p><text><SENT sid="136" pm="."><plain>To detect the role of GidA in S. suis virulence, we divided 30 6-week-old female specific-pathogen-free (SPF) Kun-Ming mice into three groups (10 mice per group). </plain></SENT>
<SENT sid="137" pm="."><plain>Groups 1 and 2 were inoculated via intraperitoneal injection with 3 × 109 CFU of either SC-19 (the LD50 for mice is 1.5 × 109 CFU) or ΔgidA. </plain></SENT>
<SENT sid="138" pm="."><plain>Saline was applied in Group 3 as negative control. </plain></SENT>
<SENT sid="139" pm="."><plain>The mice were observed for 7 days to obtain steady survival curves. </plain></SENT>
</text></p><p><text><SENT sid="140" pm="."><plain>To detect the role of GidA on colonization in different organs, we performed murine colonization assay as described previously (Marion et al., 2011). </plain></SENT>
<SENT sid="141" pm="."><plain>A total of 15 6-week-old female SPF Kun-Ming mice were inoculated intraperitoneally with 1 × 108 CFU of a 1:1 mixture of mid-log phase SC-19 and ΔgidA. </plain></SENT>
<SENT sid="142" pm="."><plain>Saline was applied as negative control in five mice. </plain></SENT>
<SENT sid="143" pm="."><plain>At 12 h, 1 day, and 3 days post infection (dpi), brain, lung, and spleen were obtained from five mice. </plain></SENT>
<SENT sid="144" pm="."><plain>The samples were homogenized after weighing, and serial dilutions were plated onto TSA agar. </plain></SENT>
<SENT sid="145" pm="."><plain>To count the colonies, we used 20 μg/ml streptomycin for SC-19, whereas 20 μg/ml streptomycin and 90 μg/ml erythromycin were used for ΔgidA. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="146" pm="."><plain>Phagocytosis assay </plain></SENT>
</text></title><p><text><SENT sid="147" pm="."><plain>To probe the resistance of each strain to phagocytosis, we performed an experiment as described previously (Li et al., 2013). </plain></SENT>
<SENT sid="148" pm="."><plain>RAW264.7 cells were scraped up and resuspended in antibiotics-free medium. </plain></SENT>
<SENT sid="149" pm="."><plain>After adhering to six-well cell culture plate (Falcon, USA), the cells were infected with SS2 at mid-log phase to reach a ratio of 10 bacteria per macrophage (MOI = 10:1). </plain></SENT>
<SENT sid="150" pm="."><plain>Phagocytosis proceeded for 30 min at 37°C and then the cells were washed with PBS thrice. </plain></SENT>
<SENT sid="151" pm="."><plain>The cells were incubated in medium containing penicillin (100 μg/ml) for 1 h at 37°C to kill extracellular bacteria. </plain></SENT>
<SENT sid="152" pm="."><plain>The culture supernatant was plated on TSA plates to confirm whether the antibiotics effectively killed the extracellular bacteria. </plain></SENT>
<SENT sid="153" pm="."><plain>The macrophages were then lysed in 1 ml of sterile distilled water. </plain></SENT>
<SENT sid="154" pm="."><plain>Viable intracellular bacteria were determined by plating a serial dilution of the lysates on TSA agar. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="155" pm="."><plain>Adhesion and invasion assays </plain></SENT>
</text></title><p><text><SENT sid="156" pm="."><plain>To evaluate the adhesion and invasion capacity of each strain, we performed an experiment as described previously (Ferrando et al., 2014). </plain></SENT>
<SENT sid="157" pm="."><plain>For the adherence assay, HEp-2 cells were infected with SS2 at mid-log phase to reach a ratio of 100 bacteria per cell (MOI = 100:1) and then incubated for 30 min at 37°C.The monolayers were washed with PBS thrice and lysed in 1 ml of sterile distilled water. </plain></SENT>
<SENT sid="158" pm="."><plain>Adherent bacteria (cell-associated bacteria) were determined by plating a serial dilution of the lysates on TSA agar. </plain></SENT>
<SENT sid="159" pm="."><plain>For invasion assay, the cells were incubated with bacteria for 2 h to allow invasion. </plain></SENT>
<SENT sid="160" pm="."><plain>The cells were subsequently incubated in medium containing penicillin (100 μg/ml) for 2 h to kill extracellular and surface-adherent bacteria. </plain></SENT>
<SENT sid="161" pm="."><plain>The monolayers were washed with PBS thrice and lysed in 1 ml of sterile distilled water. </plain></SENT>
<SENT sid="162" pm="."><plain>Invasive bacteria (intracellular bacteria) were determined by plating a serial dilution of the lysates on TSA agar. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="163" pm="."><plain>Protein extraction, digestion, and labeling with iTRAQ reagents </plain></SENT>
</text></title><p><text><SENT sid="164" pm="."><plain>SC-19 and ΔgidA cells at mid-log phase were cultured in CDM as described above. </plain></SENT>
<SENT sid="165" pm="."><plain>Three independent biological replicates were homogenized in liquid nitrogen and then precipitated using trichloroacetic acid and acetone. </plain></SENT>
<SENT sid="166" pm="."><plain>The pellets were suspended in lysis buffer (4% SDS, 100 Tris-HCl, and 1 mMDTT; pH7.6) and heated for 10 min at 100°C. </plain></SENT>
<SENT sid="167" pm="."><plain>The cell suspensions were sonicated for 5 min (10 s sonication with 15 s interval) on ice and then protein concentration in supernatants was determined through Bradford protein assay. </plain></SENT>
<SENT sid="168" pm="."><plain>Each sample (200 μg) was digested with 3 μg of trypsin (Sigma, USA) at 37°C for 16 h. </plain></SENT>
<SENT sid="169" pm="."><plain>iTRAQ labeling was performed according to the manufacturer's protocol (Applied Biosystems, Foster City, CA, USA). </plain></SENT>
<SENT sid="170" pm="."><plain>Briefly, each iTRAQ reagent was dissolved in 70 μl of ethanol and added into the peptide mixture, respectively. </plain></SENT>
<SENT sid="171" pm="."><plain>After incubation for 2 h at room temperature, the reaction was quenched by adding 0.5% formic acid. </plain></SENT>
<SENT sid="172" pm="."><plain>iTRAQ tags were labeled as follows: the three SC-19 samples were labeled with iTRAQ 114, iTRAQ 115, and iTRAQ 116; and the three ΔgidA samples were labeled with iTRAQ 117, iTRAQ 118, and iTRAQ 119. </plain></SENT>
<SENT sid="173" pm="."><plain>The labeled peptides were combined and fractionated by using strong cation exchange (SCX) chromatography. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="174" pm="."><plain>LC-MS/MS analysis </plain></SENT>
</text></title><p><text><SENT sid="175" pm="."><plain>After separation by SCX chromatography on an AKTA purifier 100 (GE Healthcare, USA), equal amounts of digested protein were loaded into a Thermo Scientific EASY column(2 cm*100 μm 5 μm-C18) and then washed with solvent A (99% H2O, and 0.1% formic acid). </plain></SENT>
<SENT sid="176" pm="."><plain>By applying solvent B (84% acetonitrile, 16% H2O, and 0.1% formic acid), the peptides were eluted from the trapping column over a Thermo scientific EASY column (75 μm*100 mm 3 μm-C18) with a gradient (0–45% B for 100 min at 250 nl/min, 35–100% B for 8 min, 100% B for 12 min) using Thermo scientific Easy nLC system. </plain></SENT>
<SENT sid="177" pm="."><plain>MS/MS was carried out with a Q-Exactive mass spectrometer (Thermo Finnigan, USA) setting in a positive ion mode and data-dependent manner choosing the most abundant precursor ions with a full MS scan from 300 to 1800 m/z, resolution of 70,000 at m/z 200. </plain></SENT>
<SENT sid="178" pm="."><plain>Determination of the target value was based on automatic gain control (AGC). </plain></SENT>
<SENT sid="179" pm="."><plain>Dynamic exclusion duration was 40 s. </plain></SENT>
<SENT sid="180" pm="."><plain>MS/MS scan was acquired at a resolution of 17,500 at m/z 200. </plain></SENT>
<SENT sid="181" pm="."><plain>Normalized collision energy was 30 eV and the under fill ratio was set at 0.1%. </plain></SENT>
<SENT sid="182" pm="."><plain>Quantitation achieved by comparison of the peak areas and resultant peak ratios for either four MS/MS reporter ions, which range from 114 to 117 Da, or eight MS/MS reporter ions, which range from 113–119 to 121 Da. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="183" pm="."><plain>Proteomic data analysis </plain></SENT>
</text></title><p><text><SENT sid="184" pm="."><plain>The acquired raw MS/MS data files were processed by Proteome Discoverer 1.4 (Thermo Scientific, USA) and searched by Mascot 2.2 (Matrix Science, Boston, MA) against the uniprot_Streptococcus_suis_23318_20150708.fasta (23,318 sequence, downloaded July 8, 2015). </plain></SENT>
<SENT sid="185" pm="."><plain>The search was conducted by applying trysin as a specific enzyme and the parameters used for normal peptides were as follows: peptide mass tolerance: 20 ppm, fragment mass tolerance: 0.1 Da, max missed cleavages: 2, fixed modifications: carbamidomethyl (C), iTRAQ8plex(K), and iTRAQ8plex(N-term), variable modifications: oxidation (M), database pattern: decoy, false-discovery rate (FDR) ≤ 0.01 (Sandberg et al., 2012). </plain></SENT>
<SENT sid="186" pm="."><plain>Each of the confident protein identification involved at least one unique peptide. </plain></SENT>
<SENT sid="187" pm="."><plain>The quantitative protein ratios were weighed and normalized by the protein median ratio in Mascot. </plain></SENT>
<SENT sid="188" pm="."><plain>To evaluate the differentially expressed (DE) proteins between ΔgidA and SC-19, we use the fold change of &gt;1.2 or &lt; 0.8333 and FDR of &lt; 0.05 to represent up- or down-regulation. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="189" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="190" pm="."><plain>Unless otherwise specified, the data were analyzed using two-tailed, unpaired t-tests and all experiments were performed in triplicate at least thrice. </plain></SENT>
<SENT sid="191" pm="."><plain>All of the data were expressed as mean standard errors of the means (SEM), and p &lt; 0.05 is the threshold for significance. </plain></SENT>
<SENT sid="192" pm="."><plain>Statistical analysis was performed on GraphPad prism 5. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="s3"><title><text><SENT sid="193" pm="."><plain>Results </plain></SENT>
</text></title><sec><title><text><SENT sid="194" pm="."><plain>Construction and characterization of ΔgidA </plain></SENT>
</text></title><p><text><SENT sid="195" pm="."><plain>The colonies sensitive to spectinomycin and resistant to erythromycin were selected as candidates of gidA deletion mutants, which were confirmed by PCR (Figure 1A), RT-PCR (Figure 1B), and Western blot analysis (Figure 1C). </plain></SENT>
<SENT sid="196" pm="."><plain>The colonies of ΔgidA appeared smaller than those of SC-19 when cultured on TSA plates overnight (Figure 2A). </plain></SENT>
<SENT sid="197" pm="."><plain>The growth curves showed that ΔgidA grew slower in the CDM than SC-19 (Figure 2B). </plain></SENT>
<SENT sid="198" pm="."><plain>However, no obvious difference in CFU counts was observed during the initial 3 h of growth. </plain></SENT>
<SENT sid="199" pm="."><plain>TEM revealed that the mean capsule was significantly thicker in ΔgidA (118 ± 5 nm) than in SC-19 (54 ± 3 nm; p &lt; 0.001; Figure 2C). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" position="float"><label>Figure 1</label><caption><p><text><SENT sid="200" pm="."><plain>Confirmation of the isogenic mutant ΔgidA. </plain></SENT>
<SENT sid="201" pm="."><plain>(A) Combined PCR analyses of the ΔgidA mutant. </plain></SENT>
<SENT sid="202" pm="."><plain>Lanes 1 and 4 represent the amplification of the upstream border of gidA using the primer set Gup-F and Gup-R. </plain></SENT>
<SENT sid="203" pm="."><plain>Lanes 2 and 5 represent the amplification of gidA using the primer set GidA-F and GidA-R. </plain></SENT>
<SENT sid="204" pm="."><plain>Lanes 3 and 6 represent the amplification of the downstream border of gidA using the primer set Gdown-F and Gdown-R. </plain></SENT>
<SENT sid="205" pm="."><plain>Lanes 1–3 use genomic DNA of SC-19 as templates, whereas Lanes 4–6 use genomic DNA of ΔgidA as templates. (B) Confirmation of the ΔgidA mutant by RT-PCR. </plain></SENT>
<SENT sid="206" pm="."><plain>Lanes 1 and 4 represent the amplification of downstream gene of gidA using the primer set 2162-F and 2162-R. </plain></SENT>
<SENT sid="207" pm="."><plain>Lanes 2 and 5 represent the amplification of gidA using primer set GidA-F and GidA-R. </plain></SENT>
<SENT sid="208" pm="."><plain>Lanes 3 and 6 represent the amplification of upstream gene of gidA using the primer set 2164-F and 2164-R. </plain></SENT>
<SENT sid="209" pm="."><plain>Lanes 1–3 use cDNA of SC-19 as templates, whereas Lanes 4–6 use cDNA of ΔgidA as templates. (C) Confirmation of the ΔgidA mutant by Western blot analysis. </plain></SENT>
<SENT sid="210" pm="."><plain>The supernatant of cell lysate from SC-19 and ΔgidA was disposed for immunoblot analysis with GidA or PGK polyclonal antibodies. </plain></SENT>
<SENT sid="211" pm="."><plain>An antibody directed against PGK was used as loading control. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-06-00044-g0001"/></fig></SecTag><SecTag type="FIG"><fig id="F2" position="float"><label>Figure 2</label><caption><p><text><SENT sid="212" pm="."><plain>Characterization of gidA mutant. </plain></SENT>
<SENT sid="213" pm="."><plain>(A) SC-19 and ΔgidA mutant cultured overnight at 37°C on TSA plates. (B) Bacterial cell density was measured spectrometrically at 600 nm, and separate aliquots of the bacterial suspensions were serially diluted and plated to determine CFU numbers per milliliter. </plain></SENT>
<SENT sid="214" pm="."><plain>Data were collected at the indicated times. (C) Transmission electron micrographs of bacteria; the bars represent 400 nm (***p &lt; 0.001). (D) Microplate showing hemolytic activity of the supernatants collected from SC-19 and ΔgidA mutant grown in CDM. </plain></SENT>
<SENT sid="215" pm="."><plain>Absorption was measured at 550 nm to determine suilysin production (***p &lt; 0.001). </plain></SENT>
<SENT sid="216" pm="."><plain>CDM was used as negative control. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-06-00044-g0002"/></fig></SecTag></sec><sec><title><text><SENT sid="217" pm="."><plain>Reduced hemolytic activity </plain></SENT>
</text></title><p><text><SENT sid="218" pm="."><plain>The hemolysin assay showed that the hemolytic activity of ΔgidA was significantly reduced compared to that of SC-19 (Figure 2D), indicating that GidA could regulate the hemolytic activity of S. suis. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="219" pm="."><plain>Attenuated virulence and decreased bacterial loads in mice </plain></SENT>
</text></title><p><text><SENT sid="220" pm="."><plain>Mice were experimentally infected to detect the role of gidA in S. suis virulence. </plain></SENT>
<SENT sid="221" pm="."><plain>All of the SC-19-infected mice displayed severe clinical symptoms, such as septicemia and meningitis during 1 dpi, and most of the infected mice (9/10) died during the 7 day observation period. </plain></SENT>
<SENT sid="222" pm="."><plain>By contrast, the ΔgidA-infected mice exhibited more slight clinical symptoms and low mortality (2/10) (Figure 3A). </plain></SENT>
<SENT sid="223" pm="."><plain>Therefore, ΔgidA virulence is markedly attenuated. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F3" position="float"><label>Figure 3</label><caption><p><text><SENT sid="224" pm="."><plain>Mouse infection experiments. </plain></SENT>
<SENT sid="225" pm="."><plain>(A) Survival curves for mice in experiment infection. </plain></SENT>
<SENT sid="226" pm="."><plain>Ten mice in each group were separately injected intraperitoneally i with 3 × 109 CFU/mice of SC-19 and ΔgidA. </plain></SENT>
<SENT sid="227" pm="."><plain>Ten mice were inoculated with saline and served as negative control. </plain></SENT>
<SENT sid="228" pm="."><plain>Significant difference in survival between different groups were analyzed by Log Rank test (p &lt; 0.05). (B) Bacteria loads in (B) brain, (C) lung, and (D) in spleen. </plain></SENT>
<SENT sid="229" pm="."><plain>The SC-19 and ΔgidA mutant strains were distinguished by erythromycin added in the TSA plates. </plain></SENT>
<SENT sid="230" pm="."><plain>Statistical significance was determined by two-tailed t-test (ns, p &gt; 0.05; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001). </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-06-00044-g0003"/></fig></SecTag><p><text><SENT sid="231" pm="."><plain>To better evaluate the pathogenecity of ΔgidA, we performed a colonization experiment by using intraperitoneal route of inoculation. </plain></SENT>
<SENT sid="232" pm="."><plain>Bacteria were recovered from brains, lungs, and spleens at different time points post infection. </plain></SENT>
<SENT sid="233" pm="."><plain>The bacterial loads in brain, lung, and spleen were much lower in ΔgidA than SC-19 from 12 h to 3 dpi, and the mutant strain was almost cleared at the 3 dpi (Figures 3B–D). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="234" pm="."><plain>Greater sensitivity to phagocytosis by RAW264.7 cells </plain></SENT>
</text></title><p><text><SENT sid="235" pm="."><plain>To investigate the role of gidA on phagocytosis of S. suis, we performed a phagocytosis assay by using RAW264.7 cells. </plain></SENT>
<SENT sid="236" pm="."><plain>The numbers of intracellular bacteria for ΔgidA (34,320 ± 3130 CFU/well) were approximately two fold higher than those of SC-19 (18430 ± 821 CFU/well; p &lt; 0.001; Figure 4A). </plain></SENT>
<SENT sid="237" pm="."><plain>This result indicates that inactivation of gidA can impair the capacity of S.suis to resist phagocytosis by macrophages. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F4" position="float"><label>Figure 4</label><caption><p><text><SENT sid="238" pm="."><plain>Phagocytosis, adhesion, and invasion assays. </plain></SENT>
<SENT sid="239" pm="."><plain>(A) Phagocytosis of S. suis by murine macrophages. </plain></SENT>
<SENT sid="240" pm="."><plain>SC-19 and ΔgidA mutant were incubated with RAW264.7 cells for 30 min at a multiplicity of infection of 10 (MOI = 10:1). </plain></SENT>
<SENT sid="241" pm="."><plain>Penicillin (100 μg/ml) was then used to kill the extracellular bacteria. </plain></SENT>
<SENT sid="242" pm="."><plain>The mutant strain ΔgidA showed significantly reduced anti-phagocytosis capability compared with SC-19 (***p &lt; 0.001). (B) The mutant strain ΔgidA showed significantly reduced levels of adherence to HEp-2 cells compared with the = degree of adherence of SC-19 (*p &lt; 0.05). (C) The mutant strain ΔgidA showed significantly reduced levels of invasion of HEp-2 cells compared with that of SC-19 (**p &lt; 0.01). </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-06-00044-g0004"/></fig></SecTag></sec><sec><title><text><SENT sid="243" pm="."><plain>Impaired adhesion and invasion capability to epithelial cells </plain></SENT>
</text></title><p><text><SENT sid="244" pm="."><plain>The adhesion assay revealed that the numbers of cell-associated bacteria of ΔgidA (63,800 ± 2437 CFU/well) were significantly lower than those of SC-19 (90,400± 7891 CFU/well; p &lt; 0.05; Figure 4B). </plain></SENT>
<SENT sid="245" pm="."><plain>In the invasion assay, the numbers of the cell intracellular bacteria of ΔgidA (2406 ± 163 CFU/well) were significantly lower than those of SC-19 (3470 ± 241 CFU/well; p &lt; 0.01; Figure 4C). </plain></SENT>
<SENT sid="246" pm="."><plain>These results suggest that deletion of gidA impairs the ability of S. suis to adhere to and invade in epithelial cells. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="247" pm="."><plain>Analysis of the DE proteins </plain></SENT>
</text></title><p><text><SENT sid="248" pm="."><plain>The iTRAQ labeling was used to identify the DE proteins in SC-19 and ΔgidA. A total of 1449 proteins were detected and quantified, 372 of which were DE proteins, including 182 up-regulated and 190 down-regulated proteins (Table S1). </plain></SENT>
</text></p><p><text><SENT sid="249" pm="."><plain>These DE proteins were annotated using Blast2GO according to biological process, molecular function, and cellular component (Figure 5). </plain></SENT>
<SENT sid="250" pm="."><plain>In terms of biological process, the 372 DE proteins were classified into 11 categories. </plain></SENT>
<SENT sid="251" pm="."><plain>The top categories with the highest number of DE proteins were metabolic process (246, 66.1%), cellular process (203, 54.6%), and single-organism process (163, 43.8%); these three functional categories are the most important in S. suis response to environmental stresses. </plain></SENT>
<SENT sid="252" pm="."><plain>In terms of molecular function, the 372 DE proteins were classified into nine categories. </plain></SENT>
<SENT sid="253" pm="."><plain>The top two categories with the highest number of DE proteins were catalytic activity (213, 57.3%) and binding (152, 40.9%). </plain></SENT>
<SENT sid="254" pm="."><plain>In terms of cellular component, the 372 DE proteins were classified into six categories. </plain></SENT>
<SENT sid="255" pm="."><plain>The top three categories with the highest number of DE proteins were cell (133, 35.8%), membrane (62, 16.7%), and macromolecular complex (54, 14.5%). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F5" position="float"><label>Figure 5</label><caption><p><text><SENT sid="256" pm="."><plain>Distribution of differentially expressed proteins according to GO annotation. </plain></SENT>
</text></p></caption><graphic xlink:href="fcimb-06-00044-g0005"/></fig></SecTag><sec><title><text><SENT sid="257" pm="."><plain>Proteins involved in growth and cell division </plain></SENT>
</text></title><p><text><SENT sid="258" pm="."><plain>Many growth- and cell division-associated proteins were regulated in the mutant strain (Table 3). </plain></SENT>
<SENT sid="259" pm="."><plain>Among these DE proteins, all of the DNA replication-, recombination- and repair-related proteins, including DNA primase RnmV, DNA gyrase (GyrA and GyrB), superfamily I DNA/RNA helicase (PcrA), site-specific recombinases (XerS andXerD), DNA repair ATPase (RecN), DNA recombination protein (RmuC), ribonucleases (RnhB, RNase H, G, and E), and 3-methyladenine DNA glycosylase (Tag), were down-regulated. </plain></SENT>
<SENT sid="260" pm="."><plain>The other DE proteins, including DivIVA, FtsQ, FtsX, FtsI, GpsB, StpK, PhpP, Cps2C, and MurD, are involved in cell division. </plain></SENT>
<SENT sid="261" pm="."><plain>Except for FtsX and GpsB, all other proteins were down-regulated. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><text><SENT sid="262" pm="."><plain>Differentially expressed proteins associated with cell growth and division, capsule synthesis, and virulence. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>Protein name </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>Locus </plain></SENT>
</text></th><th valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>Functions </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>Ratio(ΔgidA/SC-19) </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>Peptides </plain></SENT>
</text></th><th valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>Sequence coverage (%) </plain></SENT>
</text></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="6" style="background-color:#bdbec1" rowspan="1"><text><SENT sid="269" pm="."><plain>CELL GROWTH AND DIVISION </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>Cps2C </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>SSU05_0566 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>Tyrosine-protein kinase Wze </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>0.4555 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>28.57 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>DivIVA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>SSU05_0487 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>Cell division initiation protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>0.8229 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>59.83 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>– </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>SSU05_0133 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>Adenine-specific DNA methylase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>0.8010 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>34.70 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>FtsI </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>SSU05_1354 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>Cell division protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>0.8185 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>5 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>31.84 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>FtsQ </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>SSU05_0478 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>Cell division septal protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>0.8223 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>28.33 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>FtsX </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>SSU05_1410 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>Cell division protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>1.2542 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>24.60 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>GpsB </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>SSU05_0417 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>Cell division protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>1.3016 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>62.16 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>GyrA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>SSU05_1267 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>DNA gyrase subunit A </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>0.8140 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>16.43 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>GyrB </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>SSU05_1510 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>DNA gyrase subunit B </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>0.7152 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>45.38 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>MurD </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>SSU05_0476 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>0.7718 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>14 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>39.87 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>PcrA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>SSU05_0731 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>Superfamily I DNA/RNA helicase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>0.8044 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>15 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>20.42 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>PhpP </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>SSU05_0427 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>Serine/threonine protein phosphatase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>0.8067 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>11 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>59.59 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>RecN </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>SSU05_1651 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>DNA repair ATPase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>0.8321 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>14 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>35.99 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>RmuC </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>SSU05_1991 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>DNA recombination protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>0.7751 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>19.90 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>RnhB </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>SSU05_0996 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>Ribonuclease HII </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>0.8074 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>8 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>35.41 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>RnmV </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>SSU05_2010 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>DNA primase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>0.7144 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>26.53 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>RNase H </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>SSU05_0226 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>Ribonuclease HIII </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>0.7297 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>14.86 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>StkP </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>SSU05_0428 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>Serine/threonine protein kinase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>0.8129 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>5 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>32.53 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>Tag </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>SSU05_0061 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>3-methyladenine DNA glycosylase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>0.7738 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>10.58 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>– </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>SSU05_0872 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>Chromosome segregation ATPase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>0.7753 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>13 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>25.46 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>XerS </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>SSU05_0881 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>Site-specific tyrosine recombinase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>0.6361 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>5.90 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>XerD </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>SSU05_1702 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>Site-specific tyrosine recombinase XerD-like protein </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>0.5529 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>3 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>15.64 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>– </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>SSU05_1815 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>Ribonucleases G and E </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>0.6327 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>6.42 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="6" style="background-color:#bdbec1" rowspan="1"><text><SENT sid="408" pm="."><plain>CAPSULE SYNTHESIS </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>Cps2C </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>SSU05_0566 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>Tyrosine-protein kinase Wze </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>0.4555 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>28.57 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>Cps2F </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>SSU05_0569 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>Rhamnosyltransferase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>1.5931 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>10.28 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>Cps2P </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>SSU05_0578 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>Sialic acid synthase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>1.4255 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>6 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>76.63 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>Cps2Q </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>SSU05_0579 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>UNP-N-acetyglucosamine 2-epimerase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>1.2001 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>17 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>53.58 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>Cps2R </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>SSU05_0580 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>Acetyltransferase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>1.2131 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>44.23 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>Cps2S </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>SSU05_0581 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>CMP-N-acetylneuraminic acid synthetase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>1.2388 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>59.47 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" colspan="6" style="background-color:#bdbec1" rowspan="1"><text><SENT sid="445" pm="."><plain>VIRULENCE-ASSOCIATED PROTEINS </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>ArcA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>SSU05_0624 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>Arginine deiminase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>0.4071 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>15 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>43.77 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>ArcB </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>SSU05_0626 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>Ornithine carbamoyltransferase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>0.4561 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>10 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>35.91 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>ArcC </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>SSU05_0627 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>Carbamate kinase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>0.3703 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>23.17 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>DltA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>SSU05_0638 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>D-alanine-poly(phosphoribitol) ligase subunit 1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>0.8186 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>11 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>25.24 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>Enolase </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>SSU05_1503 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>Phosphopyruvate hydratase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>0.8146 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>26 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>72.64 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>GAPDH </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>SSU05_0155 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>Glyceraldehyde-3-phosphate dehydrogenase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>0.7700 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>3 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>90.77 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>GlnA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>SSU05_0160 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>Glutamine synthetase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>0.8024 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>15 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>48.21 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>GtfA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>SSU05_1555 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>Glycosidase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>0.6384 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>2 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>6.22 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>IMPDH </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>SSU05_2183 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>Inosine 5′-monophosphate dehydrogenase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>0.6649 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>1 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>45.60 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>PurA </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>SSU05_1966 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>Adenylosuccinate synthase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>0.7722 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>22 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>60.23 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>SadP </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>SSU05_0272 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>Translation initiation factor 2 GTPase </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>0.6302 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>9 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>18.43 </plain></SENT>
</text></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>Sly </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>SSU05_1403 </plain></SENT>
</text></td><td valign="top" align="left" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>Suilysin </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>0.6552 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>4 </plain></SENT>
</text></td><td valign="top" align="center" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>11.26 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec><sec><title><text><SENT sid="518" pm="."><plain>Proteins involved in CPS synthesis </plain></SENT>
</text></title><p><text><SENT sid="519" pm="."><plain>Except for Cps2C, the five enzymes involved in CPS synthesis were up-regulated in the mutant strain (Table 3). </plain></SENT>
<SENT sid="520" pm="."><plain>The induced enzymes include rhamnosyltransferase Cps2F, sialic acid synthase Cps2P, UNP-N-acetyglucosamine 2-epimerase Cps2Q, acetyltransferase Cps2R, and CMP-N-acetylneuraminic acid synthetase Cps2S. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="521" pm="."><plain>Proteins involved in virulence </plain></SENT>
</text></title><p><text><SENT sid="522" pm="."><plain>Several virulence factors were down-regulated in the mutant strain (Table 3). </plain></SENT>
<SENT sid="523" pm="."><plain>These factors include Sly, enolase, GAPDH, ADS (ArcABC), d-alanine-poly(phosphoribitol) ligase subunit 1 (DltA), glutamine synthetase (GlnA), glycosidase (GtfA), inosine 5′- monophosphate dehydrogenase (IMPDH), adenylosuccinate synthase (PurA), and translation initiation factor 2 GTPase (SadP). </plain></SENT>
</text></p></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="s4"><title><text><SENT sid="524" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="525" pm="."><plain>The tRNA modification enzyme GidA contributes to proper folding and stability of tRNA and to the correct interaction between codon and anticodon during translation in eukaryotes and prokaryotes (Fislage et al., 2014). </plain></SENT>
<SENT sid="526" pm="."><plain>GidA acts as a regulator for protein expression either by its direct effects on translation efficiency of particular gene products or through its broader effects transmitted via expression of regulators (Kinscherf and Willis, 2002). </plain></SENT>
<SENT sid="527" pm="."><plain>In several pathogenic bacteria, GidA is considered to play roles in many particular cellular processes such as growth, cell division, and virulence regulation (Shippy et al., 2011). </plain></SENT>
<SENT sid="528" pm="."><plain>However, its functions are not always the same in different bacterial species. S. suis is an important zoonotic pathogen, and the role of GidA in S. suis is unclear. </plain></SENT>
<SENT sid="529" pm="."><plain>Our study demonstrated that GidA could regulate not only growth, cell division, and capsule synthesis but also virulence of this important pathogen. </plain></SENT>
</text></p><p><text><SENT sid="530" pm="."><plain>First, a gidA deletion mutant was constructed. </plain></SENT>
<SENT sid="531" pm="."><plain>We found that the mutant ΔgidA grew much slower than the parental strain SC-19 on the TSA plate, and the size of the colonies of ΔgidA were obviously smaller than those of SC-19. </plain></SENT>
<SENT sid="532" pm="."><plain>The growth curves also confirmed the slow growth rate of the mutant strain. </plain></SENT>
<SENT sid="533" pm="."><plain>These results indicated that GidA can regulate S. suis growth. </plain></SENT>
<SENT sid="534" pm="."><plain>This finding agrees with the previous reports on E. coli (Von Meyenburg et al., 1982) and S. enterica (Rehl et al., 2013). </plain></SENT>
<SENT sid="535" pm="."><plain>To further understand the reason behind growth regulation, we performed a proteomics study. </plain></SENT>
<SENT sid="536" pm="."><plain>Numerous growth- and cell division-associated proteins were down-regulated by gidA disruption (Table 3). </plain></SENT>
<SENT sid="537" pm="."><plain>These proteins are classified into two classes: (i) DNA replication-, recombination-, and repair -related proteins, such as DNA primase (RnmV), DNA gyrase (GyrA and GyrB), DNA/RNA helicase (PcrA), site-specific recombinases (XerS and XerD), DNA repair ATPase (RecN), DNA recombination protein (RmuC), ribonucleases (RnhB, RNase H, G, and E); (ii) cell division-related proteins, including DivIVA, FtsQ, FtsI, StpK, PhpP, Cps2C, and MurD, which positively regulate cell division (Dinardo et al., 1982; Edwards and Errington, 1997; Ferreira et al., 2003; Janto et al., 2011; Šink et al., 2013; Fleurie et al., 2014; Zhu et al., 2014; Ahmed et al., 2015; Tsang and Bernhardt, 2015). </plain></SENT>
<SENT sid="538" pm="."><plain>These findings can explain the mechanism by which gidA disruption inhibits S. suis growth. </plain></SENT>
<SENT sid="539" pm="."><plain>However, two cell division-associated proteins, GpsB and FtsX, were up-regulated. </plain></SENT>
<SENT sid="540" pm="."><plain>GpsB is a negative regulator of cell division by interacting with DivIVA (Fleurie et al., 2014). </plain></SENT>
<SENT sid="541" pm="."><plain>Thus, GpsB up-regulation can inhibit cell division of S. suis. </plain></SENT>
<SENT sid="542" pm="."><plain>FtsX together with FtsE forms a dimer that act as an ABC transporter (Schmidt et al., 2004). </plain></SENT>
<SENT sid="543" pm="."><plain>The FtsEX protein complex plays a major role in regulating peptidoglycan hydrolases in response to signals from cell division (Sham et al., 2013), although the precise role of FtsX in coordinating peptidoglycan hydrolases remains unknown. </plain></SENT>
</text></p><p><text><SENT sid="544" pm="."><plain>gidA deletion significantly reduced S. suis virulence. In vivo and ex vivo studies revealed that the mutant strain displayed reduced mortality and bacterial loads in mice, reduced ability to adhere to and invade in epithelial cells, and increased sensitivity to phagocytosis. </plain></SENT>
<SENT sid="545" pm="."><plain>This finding is also consistent with the regulation of virulence in A. hydrophila (Sha et al., 2004), S. enterica (Rehl et al., 2013), and P. syringae (Kinscherf and Willis, 2002). </plain></SENT>
<SENT sid="546" pm="."><plain>The virulence attenuation in S. suis by gidA disruption can be explained by the down-regulation of some virulence factors, including Sly, enolase, GAPDH, ADS (ArcABC), DltA, and SadP (Table 3). </plain></SENT>
<SENT sid="547" pm="."><plain>Sly is one of the most important virulence factors in S. suis, and contributes to pathogen's hemolytic activity, adhesion to and invasion of epithelial cells, host colonization, and ability to cross blood-brain barrier (Charland et al., 2000; Allen et al., 2001). </plain></SENT>
<SENT sid="548" pm="."><plain>The reduced hemolytic activity of ΔgidA was confirmed by the hemolysin assay (Figure 1D). </plain></SENT>
<SENT sid="549" pm="."><plain>The ADS encoded by the operon arcABC is also involved in ability of S. suis to adhere to and invade in epithelial cells (Degnan et al., 2000; Fulde et al., 2014), and to resist oxygen depletion, nutrient starvation, and acidic environments (Gruening et al., 2006). </plain></SENT>
<SENT sid="550" pm="."><plain>DltA is involved in d-alanylation of lipoteichoic acid which contributes to the survival of S.suis (Fittipaldi et al., 2008). </plain></SENT>
<SENT sid="551" pm="."><plain>In addition, enolase, GAPDH, and SadP are three important adhesins in S. suis (Ge et al., 2004). </plain></SENT>
</text></p><p><text><SENT sid="552" pm="."><plain>Interestingly, the capsule of ΔgidA became much thicker than that of SC-19 (Figure 1C). </plain></SENT>
<SENT sid="553" pm="."><plain>This phenotype is consistent with the up-regulation of the enzymes, including Cps2F, Cps2P, Cps2Q, Cps2R, and Cps2S, which are involved in CPS synthesis (Table 3). </plain></SENT>
<SENT sid="554" pm="."><plain>In this study, only the tyrosine-protein kinase Cps2C was down-regulated. </plain></SENT>
<SENT sid="555" pm="."><plain>The orthologous protein of Cps2C in Streptococcus pneumoniae (CpsD) is a negative regulator for CPS production (Morona et al., 2003). </plain></SENT>
<SENT sid="556" pm="."><plain>To our best knowledge, this work is the first to report that CPS synthesis can be regulated by GidA in S. suis. </plain></SENT>
<SENT sid="557" pm="."><plain>CPS is considered a virulence factor in many bacteria, including S. suis (Feng et al., 2012). </plain></SENT>
<SENT sid="558" pm="."><plain>However, a report has suggested that the capsule only slightly contributes to the virulence of S. suis because both the virulent and avirulent strains can be fully encapsulated (Smith et al., 1999). </plain></SENT>
<SENT sid="559" pm="."><plain>Although the capsule of ΔgidA became thicker than that of the parental strain, the mutant strain was attenuated, and become more sensitive to phagocytosis. </plain></SENT>
<SENT sid="560" pm="."><plain>This finding is possibly affected by the use of multiple virulence factors in determination of S. suis virulence. </plain></SENT>
</text></p><p><text><SENT sid="561" pm="."><plain>There are two technical issues needed to be discussed here. </plain></SENT>
<SENT sid="562" pm="."><plain>The first one is about the complementary strain. </plain></SENT>
<SENT sid="563" pm="."><plain>We failed to create a complementary strain of the mutant (in most cases it is difficult for S. suis). </plain></SENT>
<SENT sid="564" pm="."><plain>Therefore we have performed the RT-PCR to exclude polarity effect. </plain></SENT>
<SENT sid="565" pm="."><plain>In addition, identical phenotypes were observed with independently-obtained gidA mutants. </plain></SENT>
<SENT sid="566" pm="."><plain>In our view, this fact is sufficient to rule out the remaining possibility of distant secondary mutations whose chance to occur at the same place in two independent gidA mutants is extremely low. </plain></SENT>
<SENT sid="567" pm="."><plain>The second issue is about iTRAQ. </plain></SENT>
<SENT sid="568" pm="."><plain>Concerning that GidA can affect the accuracy of protein translation, truncated, or mistranslated proteins may be produced in the gidA mutant. </plain></SENT>
<SENT sid="569" pm="."><plain>These proteins may not be detected by iTRAQ. </plain></SENT>
<SENT sid="570" pm="."><plain>The information of this part of proteins was ignored in this study. </plain></SENT>
</text></p><p><text><SENT sid="571" pm="."><plain>In conclusion, our data suggest that the tRNA modification enzyme GidA is a translational regulator for the expression of particular proteins involved in the growth, cell division, capsule synthesis, and virulence of the zoonotic S. suis. </plain></SENT>
<SENT sid="572" pm="."><plain>These findings provide a new insight that lead to our better understanding of the regulatory function of GidA in bacterial pathogens. </plain></SENT>
</text></p></sec></SecTag><SecTag type="AUTH_CONT"><sec id="s5"><title><text><SENT sid="573" pm="."><plain>Author contributions </plain></SENT>
</text></title><p><text><SENT sid="574" pm="."><plain>The experiments were performed mainly by TG, MT, and WL, and some experiments were performed with the assistance of CZ, JZ, and LZ. </plain></SENT>
<SENT sid="575" pm="."><plain>TG, LL, and TZ analyzed the data. </plain></SENT>
<SENT sid="576" pm="."><plain>The study was designed by RZ. </plain></SENT>
<SENT sid="577" pm="."><plain>TG and RZ wrote the manuscript. </plain></SENT>
</text></p><sec><title><text><SENT sid="578" pm="."><plain>Conflict of interest statement </plain></SENT>
</text></title><p><text><SENT sid="579" pm="."><plain>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="580" pm="."><plain>This work was supported by the National Basic Research Program of China (973 Program grant No. 2012CB518802) and the International S &amp; T Cooperation Program of China (ISTCP grant No. 2013DFG32360). </plain></SENT>
<SENT sid="581" pm="."><plain>We are grateful to Dr. Yosuke Murakami for providing us the pSET plasmids. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s6"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fcimb.2016.00044">http://journal.frontiersin.org/article/10.3389/fcimb.2016.00044</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table1.XLSX"><caption><p><text><SENT sid="582" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="B1"><text><SENT sid="583" pm="."><plain>AhmedW.MenonS.KarthikP. </plain></SENT>
<SENT sid="584" pm="."><plain>V. </plain></SENT>
<SENT sid="585" pm="."><plain>D. </plain></SENT>
<SENT sid="586" pm="."><plain>N. </plain></SENT>
<SENT sid="587" pm="."><plain>B.NagarajaV. (2015). Autoregulation of topoisomerase I expression by supercoiling sensitive transcription. Nucleic Acids Res. 44, 1541–1552. 10.1093/nar/gkv1088<?supplied-pmid 26496944?>26496944 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="588" pm="."><plain>AllenA. </plain></SENT>
<SENT sid="589" pm="."><plain>G.BolithoS.LindsayH.KhanS.BryantC.NortonP.. </plain></SENT>
<SENT sid="590" pm="."><plain>(2001). Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect. </plain></SENT>
<SENT sid="591" pm="."><plain>Immun. 69, 2732–2735. 10.1128/IAI.69.4.2732-2735.2001<?supplied-pmid 11254643?>11254643 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="592" pm="."><plain>BrégeonD.ColotV.RadmanM.TaddeiF. (2001). Translational misreading: a tRNA modification counteracts a +2 ribosomal frameshift. Genes Dev. 15, 2295–2306. 10.1101/gad.207701<?supplied-pmid 11544186?>11544186 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="593" pm="."><plain>CharlandN.NizetV.RubensC. </plain></SENT>
<SENT sid="594" pm="."><plain>E.KimK. </plain></SENT>
<SENT sid="595" pm="."><plain>S.LacoutureS.GottschalkM. (2000). Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect. </plain></SENT>
<SENT sid="596" pm="."><plain>Immun. 68, 637–643. 10.1128/IAI.68.2.637-643.2000<?supplied-pmid 10639427?>10639427 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="597" pm="."><plain>DegnanB. </plain></SENT>
<SENT sid="598" pm="."><plain>A.FontaineM. </plain></SENT>
<SENT sid="599" pm="."><plain>C.DoebereinerA. </plain></SENT>
<SENT sid="600" pm="."><plain>H.LeeJ. </plain></SENT>
<SENT sid="601" pm="."><plain>J.MastroeniP.DouganG.. </plain></SENT>
<SENT sid="602" pm="."><plain>(2000). Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect. </plain></SENT>
<SENT sid="603" pm="."><plain>Immun. 68, 2441–2448. 10.1128/IAI.68.5.2441-2448.2000<?supplied-pmid 10768929?>10768929 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="604" pm="."><plain>DinardoS.VoelkelK. </plain></SENT>
<SENT sid="605" pm="."><plain>A.SternglanzR.ReynoldsA. </plain></SENT>
<SENT sid="606" pm="."><plain>E.WrightA. (1982). Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes. Cell 31, 43–51. 10.1016/0092-8674(82)90403-2<?supplied-pmid 6297752?>6297752 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="607" pm="."><plain>EdwardsD. </plain></SENT>
<SENT sid="608" pm="."><plain>H.ErringtonJ. (1997). The Bacillus subtilis DivIVA protein targets to the division septum and controls the site specificity of cell division. Mol. </plain></SENT>
<SENT sid="609" pm="."><plain>Microbiol. 24, 905–915. 10.1046/j.1365-2958.1997.3811764.x<?supplied-pmid 9219999?>9219999 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="610" pm="."><plain>FengY.CaoM.ShiJ.ZhangH.HuD.ZhuJ.. </plain></SENT>
<SENT sid="611" pm="."><plain>(2012). Attenuation of Streptococcus suis virulence by the alteration of bacterial surface architecture. Sci. </plain></SENT>
<SENT sid="612" pm="."><plain>Rep. 2:710. 10.1038/srep00710<?supplied-pmid 23050094?>23050094 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="613" pm="."><plain>FengY. </plain></SENT>
<SENT sid="614" pm="."><plain>J.ZhangH. </plain></SENT>
<SENT sid="615" pm="."><plain>M.WuZ. </plain></SENT>
<SENT sid="616" pm="."><plain>W.WangS. </plain></SENT>
<SENT sid="617" pm="."><plain>H.CaoM.HuD.. </plain></SENT>
<SENT sid="618" pm="."><plain>(2014). Streptococcus suis infection an emerging/reemerging challenge of bacterial infectious diseases? Virulence 5, 477–497. 10.4161/viru.28595<?supplied-pmid 24667807?>24667807 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="619" pm="."><plain>FerrandoM. </plain></SENT>
<SENT sid="620" pm="."><plain>L.Van BaarlenP.OrrùG.PigaR.BongersR. </plain></SENT>
<SENT sid="621" pm="."><plain>S.WelsM.. </plain></SENT>
<SENT sid="622" pm="."><plain>(2014). Carbohydrate availability regulates virulence gene expression in Streptococcus suis. PLoS ONE 9:e89334. 10.1371/journal.pone.0089334<?supplied-pmid 24642967?>24642967 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="623" pm="."><plain>FerreiraH.Butler-ColeB.BurginA.BakerR.SherrattD. </plain></SENT>
<SENT sid="624" pm="."><plain>J.ArciszewskaL. </plain></SENT>
<SENT sid="625" pm="."><plain>K. (2003). Functional analysis of the C-terminal domains of the site-specific recombinases XerC and XerD. J. </plain></SENT>
<SENT sid="626" pm="."><plain>Mol. </plain></SENT>
<SENT sid="627" pm="."><plain>Biol. 330, 15–27. 10.1016/S0022-2836(03)00558-8<?supplied-pmid 12818199?>12818199 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="628" pm="."><plain>FislageM.BrosensE.DeyaertE.SpilotrosA.PardonE.LorisR.. </plain></SENT>
<SENT sid="629" pm="."><plain>(2014). SAXS analysis of the tRNA-modifying enzyme complex MnmE/MnmG reveals a novel interaction mode and GTP-induced oligomerization. Nucleic Acids Res. 42, 5978–5992. 10.1093/nar/gku213<?supplied-pmid 24634441?>24634441 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="630" pm="."><plain>FittipaldiN.SeguraM.GrenierD.GottschalkM. (2012). Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol. 7, 259–279. 10.2217/fmb.11.149<?supplied-pmid 22324994?>22324994 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="631" pm="."><plain>FittipaldiN.SekizakiT.TakamatsuD.HarelJ.Domínguez-Punaro MdeL.Von AulockS.. </plain></SENT>
<SENT sid="632" pm="."><plain>(2008). D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect. </plain></SENT>
<SENT sid="633" pm="."><plain>Immun. 76, 3587–3594. 10.1128/IAI.01568-07<?supplied-pmid 18474639?>18474639 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="634" pm="."><plain>FleurieA.ManuseS.ZhaoC.CampoN.CluzelC.LavergneJ. </plain></SENT>
<SENT sid="635" pm="."><plain>P.. </plain></SENT>
<SENT sid="636" pm="."><plain>(2014). Interplay of the serine/threonine-kinase StkP and the paralogs DivIVA and GpsB in pneumococcal cell elongation and division. PLoS Genet. 10:e1004275. 10.1371/journal.pgen.1004275<?supplied-pmid 24722178?>24722178 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="637" pm="."><plain>FuldeM.WillenborgJ.HuberC.HitzmannA.WillmsD.SeitzM.. </plain></SENT>
<SENT sid="638" pm="."><plain>(2014). The arginine-ornithine antiporter ArcD contributes to biological fitness of Streptococcus suis. Front. </plain></SENT>
<SENT sid="639" pm="."><plain>Cell. </plain></SENT>
<SENT sid="640" pm="."><plain>Infect. </plain></SENT>
<SENT sid="641" pm="."><plain>Microbiol. 4:107. 10.3389/fcimb.2014.00107<?supplied-pmid 25161959?>25161959 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="642" pm="."><plain>GeJ. </plain></SENT>
<SENT sid="643" pm="."><plain>P.CattD. </plain></SENT>
<SENT sid="644" pm="."><plain>M.GregoryR. </plain></SENT>
<SENT sid="645" pm="."><plain>L. (2004). Streptococcus mutans surface alpha-enolase binds salivary mucin MG2 and human plasminogen. Infect. </plain></SENT>
<SENT sid="646" pm="."><plain>Immun. 72, 6748–6752. 10.1128/IAI.72.11.6748-6752.2004<?supplied-pmid 15501816?>15501816 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="647" pm="."><plain>GrueningP.FuldeM.Valentin-WeigandP.GoetheR. (2006). Structure, regulation, and putative function of the arginine deiminase system of Streptococcus suis. J. </plain></SENT>
<SENT sid="648" pm="."><plain>Bacteriol. 188, 361–369. 10.1128/JB.188.2.361-369.2006<?supplied-pmid 16385025?>16385025 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="649" pm="."><plain>JacobsA. </plain></SENT>
<SENT sid="650" pm="."><plain>A.LoeffenP. </plain></SENT>
<SENT sid="651" pm="."><plain>L.Van Den BergA. </plain></SENT>
<SENT sid="652" pm="."><plain>J.StormP. </plain></SENT>
<SENT sid="653" pm="."><plain>K. (1994). Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect. </plain></SENT>
<SENT sid="654" pm="."><plain>Immun. 62, 1742–1748. <?supplied-pmid 8168935?>8168935 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="655" pm="."><plain>JantoB.AhmedA.ItoM.LiuJ.HicksD. </plain></SENT>
<SENT sid="656" pm="."><plain>B.PagniS.. </plain></SENT>
<SENT sid="657" pm="."><plain>(2011). Genome of alkaliphilic Bacillus pseudofirmus OF4 reveals adaptations that support the ability to grow in an external pH range from 7.5 to 11.4. Environ. </plain></SENT>
<SENT sid="658" pm="."><plain>Microbiol. 13, 3289–3309. 10.1111/j.1462-2920.2011.02591.x<?supplied-pmid 21951522?>21951522 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="659" pm="."><plain>JingH. </plain></SENT>
<SENT sid="660" pm="."><plain>B.YuanJ.WangJ.YuanY.ZhuL.LiuX. </plain></SENT>
<SENT sid="661" pm="."><plain>K.. </plain></SENT>
<SENT sid="662" pm="."><plain>(2008). Proteome analysis of Streptococcus suis serotype 2. Proteomics 8, 333–349. 10.1002/pmic.200600930<?supplied-pmid 18081191?>18081191 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="663" pm="."><plain>KinscherfT. </plain></SENT>
<SENT sid="664" pm="."><plain>G.WillisD. </plain></SENT>
<SENT sid="665" pm="."><plain>K. (2002). Global regulation by gidA in Pseudomonas syringae. J. </plain></SENT>
<SENT sid="666" pm="."><plain>Bacteriol. 184, 2281–2286. 10.1128/JB.184.8.2281-2286.2002<?supplied-pmid 11914360?>11914360 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="667" pm="."><plain>LiD.ShibataY.TakeshitaT.YamashitaY. (2014). A novel gene involved in the survival of Streptococcus mutans under stress conditions. Appl. </plain></SENT>
<SENT sid="668" pm="."><plain>Environ. </plain></SENT>
<SENT sid="669" pm="."><plain>Microbiol. 80, 97–103. 10.1128/AEM.02549-13<?supplied-pmid 24123744?>24123744 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="670" pm="."><plain>LiW.HuX.LiuL.ChenH.ZhouR. (2011). Induction of protective immune response against Streptococcus suis serotype 2 infection by the surface antigen HP0245. FEMS Microbiol. </plain></SENT>
<SENT sid="671" pm="."><plain>Lett. 316, 115–122. 10.1111/j.1574-6968.2010.02200.x<?supplied-pmid 21204934?>21204934 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="672" pm="."><plain>LiW.LiuL.ChenH.ZhouR. (2009). Identification of Streptococcus suis genes preferentially expressed under iron starvation by selective capture of transcribed sequences. FEMS Microbiol. </plain></SENT>
<SENT sid="673" pm="."><plain>Lett. 292, 123–133. 10.1111/j.1574-6968.2008.01476.x<?supplied-pmid 19191874?>19191874 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="674" pm="."><plain>LiW.LiuL.QiuD.ChenH.ZhouR. (2010). Identification of Streptococcus suis serotype 2 genes preferentially expressed in the natural host. Int. </plain></SENT>
<SENT sid="675" pm="."><plain>J. </plain></SENT>
<SENT sid="676" pm="."><plain>Med. </plain></SENT>
<SENT sid="677" pm="."><plain>Microbiol. 300, 482–488. 10.1016/j.ijmm.2010.04.018<?supplied-pmid 20554247?>20554247 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="678" pm="."><plain>LiW.WanY.TaoZ.ChenH.ZhouR. (2013). A novel fibronectin-binding protein of Streptococcus suis serotype 2 contributes to epithelial cell invasion and in vivo dissemination. Vet. </plain></SENT>
<SENT sid="679" pm="."><plain>Microbiol. 162, 186–194. 10.1016/j.vetmic.2012.09.004<?supplied-pmid 23021642?>23021642 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="680" pm="."><plain>LunZ. </plain></SENT>
<SENT sid="681" pm="."><plain>R.WangQ. </plain></SENT>
<SENT sid="682" pm="."><plain>P.ChenX. </plain></SENT>
<SENT sid="683" pm="."><plain>G.LiA. </plain></SENT>
<SENT sid="684" pm="."><plain>X.ZhuX. </plain></SENT>
<SENT sid="685" pm="."><plain>Q. (2007). Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect. </plain></SENT>
<SENT sid="686" pm="."><plain>Dis. 7, 201–209. 10.1016/S1473-3099(07)70001-4<?supplied-pmid 17317601?>17317601 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="687" pm="."><plain>MarionC.AtenA. </plain></SENT>
<SENT sid="688" pm="."><plain>E.WoodigaS. </plain></SENT>
<SENT sid="689" pm="."><plain>A.KingS. </plain></SENT>
<SENT sid="690" pm="."><plain>J. (2011). Identification of an ATPase, MsmK, which energizes multiple carbohydrate ABC transporters in Streptococcus pneumoniae. Infect. </plain></SENT>
<SENT sid="691" pm="."><plain>Immun. 79, 4193–4200. 10.1128/IAI.05290-11<?supplied-pmid 21825065?>21825065 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="692" pm="."><plain>MoronaJ. </plain></SENT>
<SENT sid="693" pm="."><plain>K.MoronaR.MillerD. </plain></SENT>
<SENT sid="694" pm="."><plain>C.PatonJ. </plain></SENT>
<SENT sid="695" pm="."><plain>C. (2003). Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. J. </plain></SENT>
<SENT sid="696" pm="."><plain>Bacteriol. 185, 3009–3019. 10.1128/JB.185.10.3009-3019.2003<?supplied-pmid 12730159?>12730159 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="697" pm="."><plain>RehlJ. </plain></SENT>
<SENT sid="698" pm="."><plain>M.ShippyD. </plain></SENT>
<SENT sid="699" pm="."><plain>C.EakleyN. </plain></SENT>
<SENT sid="700" pm="."><plain>M.BrevikM. </plain></SENT>
<SENT sid="701" pm="."><plain>D.SandJ. </plain></SENT>
<SENT sid="702" pm="."><plain>M.CookM. </plain></SENT>
<SENT sid="703" pm="."><plain>E.. </plain></SENT>
<SENT sid="704" pm="."><plain>(2013). GidA expression in Salmonella is modulated under certain environmental conditions. Curr. </plain></SENT>
<SENT sid="705" pm="."><plain>Microbiol. 67, 279–285. 10.1007/s00284-013-0361-2<?supplied-pmid 23579313?>23579313 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="706" pm="."><plain>SandbergA.LindellG.KällströmB. </plain></SENT>
<SENT sid="707" pm="."><plain>N.BrancaR. </plain></SENT>
<SENT sid="708" pm="."><plain>M.DanielssonK. </plain></SENT>
<SENT sid="709" pm="."><plain>G.DahlbergM.. </plain></SENT>
<SENT sid="710" pm="."><plain>(2012). Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes. Mol. </plain></SENT>
<SENT sid="711" pm="."><plain>Cell. </plain></SENT>
<SENT sid="712" pm="."><plain>Proteomics 11:M112.016998. 10.1074/mcp.M112.016998<?supplied-pmid 22499770?>22499770 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="713" pm="."><plain>SchmidtK. </plain></SENT>
<SENT sid="714" pm="."><plain>L.PetersonN. </plain></SENT>
<SENT sid="715" pm="."><plain>D.KustuschR. </plain></SENT>
<SENT sid="716" pm="."><plain>J.WisselM. </plain></SENT>
<SENT sid="717" pm="."><plain>C.GrahamB.PhillipsG. </plain></SENT>
<SENT sid="718" pm="."><plain>J.. </plain></SENT>
<SENT sid="719" pm="."><plain>(2004). A predicted ABC transporter, FtsEX, is needed for cell division in Escherichia coli. J. </plain></SENT>
<SENT sid="720" pm="."><plain>Bacteriol. 186, 785–793. 10.1128/JB.186.3.785-793.2004<?supplied-pmid 14729705?>14729705 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="721" pm="."><plain>ShaJ.KozlovaE. </plain></SENT>
<SENT sid="722" pm="."><plain>V.FadlA. </plain></SENT>
<SENT sid="723" pm="."><plain>A.OlanoJ. </plain></SENT>
<SENT sid="724" pm="."><plain>P.HoustonC. </plain></SENT>
<SENT sid="725" pm="."><plain>W.PetersonJ. </plain></SENT>
<SENT sid="726" pm="."><plain>W.. </plain></SENT>
<SENT sid="727" pm="."><plain>(2004). Molecular characterization of a glucose-inhibited division gene, gidA, that regulates cytotoxic enterotoxin of Aeromonas hydrophila. Infect. </plain></SENT>
<SENT sid="728" pm="."><plain>Immun. 72, 1084–1095. 10.1128/IAI.72.2.1084-1095.2004<?supplied-pmid 14742556?>14742556 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="729" pm="."><plain>ShamL. </plain></SENT>
<SENT sid="730" pm="."><plain>T.JensenK. </plain></SENT>
<SENT sid="731" pm="."><plain>R.BruceK. </plain></SENT>
<SENT sid="732" pm="."><plain>E.WinklerM. </plain></SENT>
<SENT sid="733" pm="."><plain>E. (2013). Involvement of FtsE ATPase and FtsX extracellular loops 1 and 2 in FtsEX-PcsB complex function in cell division of Streptococcus pneumoniae D39. Mbio 4:e00431–13. 10.1128/mBio.00431-13<?supplied-pmid 23860769?>23860769 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="734" pm="."><plain>ShiR.VillarroyaM.Ruiz-PartidaR.LiY.ProteauA.PradoS.. </plain></SENT>
<SENT sid="735" pm="."><plain>(2009). Structure-function analysis of Escherichia coli MnmG (GidA), a highly conserved tRNA-modifying enzyme. J. </plain></SENT>
<SENT sid="736" pm="."><plain>Bacteriol. 191, 7614–7619. 10.1128/JB.00650-09<?supplied-pmid 19801413?>19801413 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="737" pm="."><plain>ShippyD. </plain></SENT>
<SENT sid="738" pm="."><plain>C.EakleyN. </plain></SENT>
<SENT sid="739" pm="."><plain>M.BochslerP. </plain></SENT>
<SENT sid="740" pm="."><plain>N.ChopraA. </plain></SENT>
<SENT sid="741" pm="."><plain>K.FadlA. </plain></SENT>
<SENT sid="742" pm="."><plain>A. (2011). Biological and virulence characteristics of Salmonella enterica serovar Typhimurium following deletion of glucose-inhibited division (gidA) gene. Microb. </plain></SENT>
<SENT sid="743" pm="."><plain>Pathog. 50, 303–313. 10.1016/j.micpath.2011.02.004<?supplied-pmid 21320585?>21320585 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="744" pm="."><plain>ShippyD. </plain></SENT>
<SENT sid="745" pm="."><plain>C.HeintzJ. </plain></SENT>
<SENT sid="746" pm="."><plain>A.AlbrechtR. </plain></SENT>
<SENT sid="747" pm="."><plain>M.EakleyN. </plain></SENT>
<SENT sid="748" pm="."><plain>M.ChopraA. </plain></SENT>
<SENT sid="749" pm="."><plain>K.FadlA. </plain></SENT>
<SENT sid="750" pm="."><plain>A. (2012). Deletion of glucose-inhibited division (gidA) gene alters the morphological and replication characteristics of Salmonella enterica Serovar typhimurium. Arch. </plain></SENT>
<SENT sid="751" pm="."><plain>Microbiol. 194, 405–412. 10.1007/s00203-011-0769-7<?supplied-pmid 22109813?>22109813 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="752" pm="."><plain>ŠinkR.BarreteauH.PatinD.Mengin-LecreulxD.GobecS.BlanotD. (2013). MurD enzymes: some recent developments. Biomol. </plain></SENT>
<SENT sid="753" pm="."><plain>Concepts 4, 539–556. 10.1515/bmc-2013-0024<?supplied-pmid 25436755?>25436755 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="754" pm="."><plain>SmithH. </plain></SENT>
<SENT sid="755" pm="."><plain>E.DammanM.Van Der VeldeJ.WagenaarF.WisselinkH. </plain></SENT>
<SENT sid="756" pm="."><plain>J.Stockhofe-ZurwiedenN.. </plain></SENT>
<SENT sid="757" pm="."><plain>(1999). Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. </plain></SENT>
<SENT sid="758" pm="."><plain>Immun. 67, 1750–1756. <?supplied-pmid 10085014?>10085014 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="759" pm="."><plain>TakamatsuD.OsakiM.SekizakiT. (2001). Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid 46, 140–148. 10.1006/plas.2001.1532<?supplied-pmid 11591139?>11591139 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="760" pm="."><plain>TanM. </plain></SENT>
<SENT sid="761" pm="."><plain>F.GaoT.LiuW. </plain></SENT>
<SENT sid="762" pm="."><plain>Q.ZhangC. </plain></SENT>
<SENT sid="763" pm="."><plain>Y.YangX.ZhuJ. </plain></SENT>
<SENT sid="764" pm="."><plain>W.. </plain></SENT>
<SENT sid="765" pm="."><plain>(2015). MsmK, an ATPase, contributes to utilization of multiple carbohydrates and host colonization of Streptococcus suis. PLoS ONE 10:e0130792. 10.1371/journal.pone.0130792<?supplied-pmid 26222651?>26222651 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="766" pm="."><plain>Trieu-CuotP.CarlierC.Poyart-SalmeronC.CourvalinP. (1991). Shuttle vectors containing a multiple cloning site and a lacZ alpha gene for conjugal transfer of DNA from Escherichia coli to gram-positive bacteria. Gene 102, 99–104. 10.1016/0378-1119(91)90546-N<?supplied-pmid 1864514?>1864514 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="767" pm="."><plain>TsangM. </plain></SENT>
<SENT sid="768" pm="."><plain>J.BernhardtT. </plain></SENT>
<SENT sid="769" pm="."><plain>G. (2015). A role for the FtsQLB complex in cytokinetic ring activation revealed by an ftsL allele that accelerates division. Mol. </plain></SENT>
<SENT sid="770" pm="."><plain>Microbiol. 95, 925–944. 10.1111/mmi.12905<?supplied-pmid 25496050?>25496050 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="771" pm="."><plain>Van De RijnI.KesslerR. </plain></SENT>
<SENT sid="772" pm="."><plain>E. (1980). Growth characteristics of group A streptococci in a new chemically defined medium. Infect. </plain></SENT>
<SENT sid="773" pm="."><plain>Immun. 27, 444–448. <?supplied-pmid 6991416?>6991416 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="774" pm="."><plain>Von MeyenburgK.JørgensenB. </plain></SENT>
<SENT sid="775" pm="."><plain>B.NielsenJ.HansenF. </plain></SENT>
<SENT sid="776" pm="."><plain>G. (1982). Promoters of the atp operon coding for the membrane-bound ATP synthase of Escherichia coli mapped by Tn10 insertion mutations. Mol. </plain></SENT>
<SENT sid="777" pm="."><plain>Gen. </plain></SENT>
<SENT sid="778" pm="."><plain>Genet. 188, 240–248. 10.1007/BF00332682<?supplied-pmid 6185823?>6185823 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="779" pm="."><plain>WertheimH. </plain></SENT>
<SENT sid="780" pm="."><plain>F.NghiaH. </plain></SENT>
<SENT sid="781" pm="."><plain>D.TaylorW.SchultszC. (2009). Streptococcus suis: an emerging human pathogen. Clin. </plain></SENT>
<SENT sid="782" pm="."><plain>Infect. </plain></SENT>
<SENT sid="783" pm="."><plain>Dis. 48, 617–625. 10.1086/596763<?supplied-pmid 19191650?>19191650 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="784" pm="."><plain>YimL.MoukadiriI.BjörkG. </plain></SENT>
<SENT sid="785" pm="."><plain>R.ArmengodM. </plain></SENT>
<SENT sid="786" pm="."><plain>E. (2006). Further insights into the tRNA modification process controlled by proteins MnmE and GidA of Escherichia coli. Nucleic Acids Res. 34, 5892–5905. 10.1093/nar/gkl752<?supplied-pmid 17062623?>17062623 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="787" pm="."><plain>YuH.JingH.ChenZ.ZhengH.ZhuX.WangH.. </plain></SENT>
<SENT sid="788" pm="."><plain>(2006). Human Streptococcus suis outbreak, Sichuan, China. Emerging Infect. </plain></SENT>
<SENT sid="789" pm="."><plain>Dis. 12, 914–920. 10.3201/eid1206.051194<?supplied-pmid 16707046?>16707046 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="790" pm="."><plain>ZhangT.DingY.LiT.WanY.LiW.ChenH.. </plain></SENT>
<SENT sid="791" pm="."><plain>(2012). A Fur-like protein PerR regulates two oxidative stress response related operons dpr and metQIN in Streptococcus suis. BMC Microbiol. 12:85. 10.1186/1471-2180-12-85<?supplied-pmid 22646062?>22646062 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="792" pm="."><plain>ZhangW.ZhaoZ.ZhangB.WuX. </plain></SENT>
<SENT sid="793" pm="."><plain>G.RenZ. </plain></SENT>
<SENT sid="794" pm="."><plain>G.ZhangL. </plain></SENT>
<SENT sid="795" pm="."><plain>Q. (2014). Posttranscriptional regulation of 2,4-diacetylphloroglucinol production by GidA and TrmE in Pseudomonas fluorescens 2P24. Appl. </plain></SENT>
<SENT sid="796" pm="."><plain>Environ. </plain></SENT>
<SENT sid="797" pm="."><plain>Microbiol. 80, 3972–3981. 10.1128/AEM.00455-14<?supplied-pmid 24747907?>24747907 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="798" pm="."><plain>ZhengF.JiH.CaoM.WangC.FengY.LiM.. </plain></SENT>
<SENT sid="799" pm="."><plain>(2011). Contribution of the Rgg transcription regulator to metabolism and virulence of Streptococcus suis serotype 2. Infect. </plain></SENT>
<SENT sid="800" pm="."><plain>Immun. 79, 1319–1328. 10.1128/IAI.00193-10<?supplied-pmid 21149588?>21149588 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="801" pm="."><plain>ZhuH.ZhouJ.NiY.YuZ.MaoA.HuY.. </plain></SENT>
<SENT sid="802" pm="."><plain>(2014). Contribution of eukaryotic-type serine/threonine kinase to stress response and virulence of Streptococcus suis. PLoS ONE 9:e91971. 10.1371/journal.pone.0091971<?supplied-pmid 24637959?>24637959 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
